Journal
/
Immunology and Infection
/
Rilevazione dell'anticorpo sars-CoV-2 Receptor-Binding Domain utilizzando un bioreporter basato su HiBiT…
JoVE Journal
Immunology and Infection
Immunology and Infection
A subscription to JoVE is required to view this content.
Rilevazione dell'anticorpo sars-CoV-2 Receptor-Binding Domain utilizzando un bioreporter basato su HiBiT
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/62488-v
•
07:44 min
•
August 12th, 2021
Rilevazione dell'anticorpo sars-CoV-2 Receptor-Binding Domain utilizzando un bioreporter basato su HiBiT
August 12th, 2021
•
Reza Rezaei1,2, Abera Surendran1,2, Ragunath Singaravelu1,2, Taylor R. Jamieson1,2, Parisa Taklifi3, Joanna Poutou1,2, Taha Azad1,2, Carolina S. Ilkow1,2
Chapters
Summary
Please note that all translations are automatically generated.
Click here for the English version.
Il protocollo delineato descrive la procedura per la produzione del complesso proteico del dominio legante il recettore HiBiT e la sua applicazione per il rilevamento rapido e sensibile degli anticorpi SARS-CoV-2.